Sutro Biopharma, Inc.
NASDAQ: STRO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jane Chung
- Employees
- 269
- Headquarters
- South San Francisco, United States
- IPO year
- 2018
- Market cap
- $290.6M
- Website
- https://www.sutrobio.com
Loading STRO…
Loading profile data…Frequently asked questions about STRO
What does Sutro Biopharma, Inc. (STRO) do?
Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platf...
Where does STRO trade?
Sutro Biopharma, Inc. (STRO) trades on the NASDAQ Global Market.
What sector is STRO in?
Sutro Biopharma, Inc. (STRO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sutro Biopharma, Inc.?
Jane Chung is the chief executive officer of Sutro Biopharma, Inc. (STRO).
Where is Sutro Biopharma, Inc. headquartered?
Sutro Biopharma, Inc. is headquartered in United States.
Does STRO pay a dividend?
Sutro Biopharma, Inc. (STRO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STRO go public?
Sutro Biopharma, Inc. (STRO) completed its initial public offering in 2018.